Clinical trial
Prospective, Multricentre, Non Controlled, Non-randomized, Open Study for the Evaluation of the Cementless Anatomic Femoral Stem MiniMAX
NCT06012656 is registered in ClinicalTrials.gov with Medacta International SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Multricentre, Non Controlled, Non-randomized, Open Study for the Evaluation of the Cementless Anatomic Femoral Stem MiniMAX
- Lead sponsor
- Medacta International SA
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 2, 2019
- Completion date
- January 2, 2031
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
avascular necrosis, congenital hip dysplasia, fracture; femur, head, primary osteoarthritis, rheumatoid arthritis, secondary osteoarthritis, traumatic arthritis